Health ❯ Medical Research

Drug Development

Clinical Trials Therapeutics AI in Healthcare AI in Medicine Targeted Therapy Disease Modeling Targeted Therapies Phase 3 Trials Nanotechnology Biotechnology Cancer Research Protein Targets Clinical Testing Protein Biology Cancer Treatment DNA-Encoded Chemical Libraries Protein Structure Prediction Vaccines Disease Treatment Viral Inactivation Protein-Based Therapies Protein-based Drugs Synthetic Proteins Therapeutic Design Antibiotics Investigational Therapies Molecular Biology Anti-Aging Treatments Chemical Reactions Breakthroughs Therapeutic Options Aduhelm Efficacy Therapeutic Response Vaccine Research Regulatory Approval Life-saving Drugs Structural Biology Oncology Cardiotoxicity Testing Clinical Guidelines Photopharmacology Protein Interactions Antiparasitic Drugs Vaccine Targets Antiviral Drugs Inflammatory Diseases Combination Therapy FDA Regulations Monoclonal Antibodies Gout Treatment New Treatments Innovative Treatments Testing Methods Ophthalmic Solutions Disease Mechanisms Hunger Disorders Neurological Disorders Research Methodologies Pharmaceuticals FDA Approval Antimalarial Drugs Personalized Medicine Innovative Therapies Safety Trials Chemical Proteomics Cell-specific pharmacological testing Pathogen Targeting

Mitochondrial Map and Reannotated Genome Reveal How Acanthamoeba Survives Low Oxygen

The datasets offer a road map to selectively target Acanthamoeba mitochondria to reduce toxicity of current treatments.

Kissick Foundation and Milken Institute Award $2.5 Million for Sporadic FTD Research

Enveda’s ENV-308 Clears Phase 1 Safety Test

Scientists Map Bacterial Blueprint That Builds a Natural HDAC Cancer Drug

Fish‑Inspired Sensor Tracks Beats of Lab‑Grown Human Heart Tissue

Eli Lilly Licenses AlzeCure’s Preclinical Alzheimer’s Candidate

NanoMesh Nanofiber Implant Doubles Survival in Mouse Glioblastoma Models

Regeneron Strikes Parabilis Deal to Develop Antibody-Helicon Drugs

Isomorphic Labs Raises $2.1 Billion to Scale AI Drug Design

OpenAI Launches GPT-Rosalind, a Biology-Tuned AI for Drug Discovery

Investor Lawsuits Target Gossamer Bio Over Failed PROSERA Trial

MRI Reveals Long-Lasting Blood–Brain Barrier Damage in Retired Contact‑Sport Athletes

Sobi to Acquire Arthrosi in Up to $1.5 Billion Deal to Bolster Gout Portfolio

Five Years On, AlphaFold Propels Asia-Pacific Research Breakthroughs

Johnson & Johnson to Buy Halda Therapeutics for $3.05 Billion to Bolster Oncology Pipeline

Scripps Team Designs Ultra-Stable Synthetic Membrane Proteins to Decode Common Folding Motif

FDA Clears UCLA’s ENPP1-Blocking Antibody AD-NP1 for First-in-Human Trial

Teva Wins FDA Fast Track for Emrusolmin in Multiple System Atrophy

CUNY Study Unveils Sugar-Targeting Compounds With Broad Antiviral Activity

Abandoned Cholesterol Drug Lapaquistat to Undergo Zambian Trials Against Cryptosporidiosis